Pharmaceutical Formulations of Nanotechnology-Based Drug Delivery Systems for Antimicrobial Applications: A Review

Authors

  • Muhammad Zubair Department of Botany, University of Science and Technology Bannu, KP, Pakistan.
  • Boyinbode Ebenezer Ayomide Department of Chemistry, University of Medical Sciences, Ondo, Nigeria.
  • Musadiq Manzoor Department of Botany, University of Karachi, Sindh, Pakistan.
  • Saad Najam Department of Pharmacology, Jinnah Medical and Dental College, Sohail University, Karachi, Sindh, Pakistan.
  • Maria Soomro Faculty of Pharmacy, University of Sindh, Jamshoro, Sindh, Pakistan.
  • Musab Binyameen Faculty of Pharmacy, Gomal University, D.I. Khan, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i8.2176

Keywords:

Pharmaceutical Formulations, Drug Delivery Systems, Antimicrobial Applications, A Review, Resistant Pathogens, Antimicrobial Resistance

Abstract

Antimicrobial resistance (AMR) is on the rise globally, so creating new tools to combat resistant pathogens is essential. A novel approach that enhances the therapeutic potential of antimicrobial compounds by avoiding resistance mechanisms and reducing systemic side effects is the nanotechnologically based drug delivery system, or Nano-DDS. The preparation and application of pharmaceutical formulations containing nanomaterials, such as liposomes, polymeric nanoparticles, metallic nanoparticles, dendrimers, and carbon-based nanomaterials in antimicrobial therapy, are compiled in this review. Such systems address deadly multidrug-resistant organisms like MRSA and MDR-TB, as well as fungal and viral infections, by overcoming the poor solubility of drugs, enabling site-specific delivery, and promoting drug penetration inside microbial biofilms. Clinical and preclinical studies illustrating the potential of recent developments, such as theragnostic systems and stimuli-responsive nanocarriers, are discussed. Along with examining issues like toxicity, scalability, and regulatory barriers, the review offers solutions for safe clinical translation. Prospects for the future emphasize how nanotechnology can be integrated with artificial intelligence and CRISPR for personalized medicine. This review emphasizes how important nanotechnology is in combating AMR and calls for interdisciplinary cooperation to hasten its clinical adoption and fight the escalating global health emergency.

Downloads

Download data is not yet available.

References

1. Upponi, J. R., & Torchilin, V. P. (2014). Passive vs. active targeting: An update of the EPR role in drug delivery to tumors. Advances in Delivery Science and Technology, 3-45.

https://doi.org/10.1007/978-3-319-08084-0_1

2. Ventola, C. L. (2015). The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics, 40(4), 277.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4378521/

3. Makabenta, J. M., Nabawy, A., Li, C., Schmidt-Malan, S., Patel, R., & Rotello, V. M. (2020). Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nature Reviews Microbiology, 19(1), 23-36.

https://doi.org/10.1038/s41579-020-0420-1

4. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751-760.

https://doi.org/10.1038/nnano.2007.387

5. Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H., Chen, Y., Lenzo, J. C., Holden, J. A., Blencowe, A., Reynolds, E. C., & Qiao, G. G. (2016). Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. Nature Microbiology, 1(11).

https://doi.org/10.1038/nmicrobiol.2016.162

6. Müller, R., Jacobs, C., & Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy. Advanced Drug Delivery Reviews, 47(1), 3-19.

https://doi.org/10.1016/s0169-409x(00)00118-6

7. Panyam, J., & Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews, 55(3), 329-347.

https://doi.org/10.1016/s0169-409x(02)00228-4

8. SVENSON, S., & TOMALIA, D. (2005). Dendrimers in biomedical applications—reflections on the field. Advanced Drug Delivery Reviews, 57(15), 2106-2129.

https://doi.org/10.1016/j.addr.2005.09.018

9. Wang, R., Billone, P. S., & Mullett, W. M. (2013). Nanomedicine in action: An overview of cancer Nanomedicine on the market and in clinical trials. Journal of Nanomaterials, 2013(1).

https://doi.org/10.1155/2013/629681

10. Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2020). Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery, 20(2), 101-124.

https://doi.org/10.1038/s41573-020-0090-8

11. Chen, X., Fernando, G. J. P., Crichton, M. L., Flaim, C., Yukiko, S. R., Fairmaid, E. J., Corbett, H. J., Primiero, C. A., Ansaldo, A. B., Frazer, I. H., Brown, L. E., & Kendall, M. A. F. (2011). Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. Journal of Controlled Release, 152(3), 349–355.

https://doi.org/10.1016/j.jconrel.2011.02.026

12. Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009). Understanding biophysicochemical interactions at the nano–bio interface. Nature Materials, 8(7), 543-557.

https://doi.org/10.1038/nmat2442

13. Lee, S., Moon, J. J., & West, J. L. (2008). Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration. Biomaterials, 29(20), 2962-2968.

https://doi.org/10.1016/j.biomaterials.2008.04.004

14. Covey, L. S., Sullivan, M. A., Johnston, J. A., Glassman, A. H., Robinson, M. D., & Adams, D. P. (2000). Advances in non-nicotine pharmacotherapy for smoking cessation. Drugs, 59(1), 17-31.

https://doi.org/10.2165/00003495-200059010-00003

15. Hemeg, H. (2017). Nanomaterials for alternative antibacterial therapy. International Journal of Nanomedicine, 12, 8211-8225.

https://doi.org/10.2147/ijn.s132163

16. Puneet, P., Podila, R., He, J., Rao, A. M., Howard, A., Cornell, N., & Zakhidov, A. A. (2015). Synthesis and superconductivity in spark plasma sintered pristine and graphene-doped FeSe0.5 Te0.5. Nanotechnology Reviews, 4(5), 411-417.

https://doi.org/10.1515/ntrev-2015-0018

17. Vong, L. B., Mo, J., Abrahamsson, B., & Nagasaki, Y. (2015). Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose–response efficacy. Journal of Controlled Release, 210, 19-25.

https://doi.org/10.1016/j.jconrel.2015.05.275

18. Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16(10), 2346-2353.

https://doi.org/10.1088/0957-4484/16/10/059

19. Mohan, C. C., Cherian, A. M., Kurup, S., Joseph, J., Nair, M. B., Vijayakumar, M., Nair, S. V., & Menon, D. (2017). Stable Titania Nanostructures on stainless steel coronary stent surface for enhanced corrosion resistance and Endothelialization. Advanced Healthcare Materials, 6(11).

https://doi.org/10.1002/adhm.201601353

20. Negredo, E., Langohr, K., Bonjoch, A., Pérez-Alvárez, N., Estany, C., Puig, J., Rosales, J., Echeverría, P., Clotet, B., & Gómez, G. (2018). High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: The role of PIs. Journal of Antimicrobial Chemotherapy, 73(9), 2452-2459.

https://doi.org/10.1093/jac/dky201

21. Austerberry, J. I., Dajani, R., Panova, S., Roberts, D., Golovanov, A. P., Pluen, A., Van der Walle, C. F., Uddin, S., Warwicker, J., Derrick, J. P., & Curtis, R. (2017). The effect of charge mutations on the stability and aggregation of a human single chain Fv fragment. European Journal of Pharmaceutics and Biopharmaceutics, 115, 18-30.

https://doi.org/10.1016/j.ejpb.2017.01.019

22. Hemeg, H. (2017). Nanomaterials for alternative antibacterial therapy. International Journal of Nanomedicine, 12, 8211-8225.

https://doi.org/10.2147/ijn.s132163

23. Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Manuel, R., & Brown, C. S. (2018). Candida auris: A review of the literature. Clinical Microbiology Reviews, 31(1).

https://doi.org/10.1128/cmr.00029-17

24. Yang, Y., Ou, R., Guan, S., Ye, X., Hu, B., Zhang, Y., Lu, S., Zhou, Y., Yuan, Z., Zhang, J., & Li, Q. (2014). A novel drug delivery gel of terbinafine hydrochloride with high penetration for external use. Drug Delivery, 22(8), 1086-1093.

https://doi.org/10.3109/10717544.2013.878856

25. Ogawa, E., Furusyo, N., Kajiwara, E., Nomura, H., Dohmen, K., Takahashi, K., Nakamuta, M., Satoh, T., Azuma, K., Kawano, A., Tanabe, Y., Kotoh, K., Shimoda, S., & Hayashi, J. (2014). Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection. Antiviral Research, 104, 102-109.

https://doi.org/10.1016/j.antiviral.2014.01.004

26. Vong, L. B., Mo, J., Abrahamsson, B., & Nagasaki, Y. (2015). Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose–response efficacy. Journal of Controlled Release, 210, 19-25.

https://doi.org/10.1016/j.jconrel.2015.05.275

27. Li, Y., Xiao, K., Zhu, W., Deng, W., & Lam, K. S. (2014). Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Advanced Drug Delivery Reviews, 66, 58-73.

https://doi.org/10.1016/j.addr.2013.09.008

28. Nel, A., Xia, T., Mädler, L., & Li, N. (2006). Toxic potential of materials at the Nanolevel. Science, 311(5761), 622-627.

https://doi.org/10.1126/science.1114397

29. Yin, H., Tseng, H., Chung, H., Ko, C., Tzou, W., Buhler, D. R., & Hu, C. (2008). Influence of TCDD on Zebrafish CYP1B1 transcription during development. Toxicological Sciences, 103(1), 158-168.

https://doi.org/10.1093/toxsci/kfn035

30. Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014). Nanomedicines: Addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences, 1313(1), 35-56.

https://doi.org/10.1111/nyas.12403

31. Tsai, W., & Lin, H. (2016). The integrity of two sides. Nature Materials, 15(9), 927-928.

https://doi.org/10.1038/nmat4700

32. Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12(11), 991-1003.

https://doi.org/10.1038/nmat3776

33. Mura, S., & Couvreur, P. (2012). Nanotheranostics for personalized medicine. Advanced Drug Delivery Reviews, 64(13), 1394-1416.

https://doi.org/10.1016/j.addr.2012.06.006

34. Brousseau, N., Slack, M. P., Waight, P., Borrow, R., & Ladhani, S. N. (2015). Reply to musher. Clinical Infectious Diseases, 62(1), 133-134.

https://doi.org/10.1093/cid/civ811

35. Zhang, H., & Wang, Z. (2019). Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals. International Journal of Pharmaceutics, 565, 283-293.

https://doi.org/10.1016/j.ijpharm.2019.05.021

36. Nguyen, Q., & Yokota, T. (2017). Immortalized muscle cell model to test the exon skipping efficacy for duchenne muscular dystrophy. Journal of Personalized Medicine, 7(4), 13.

https://doi.org/10.3390/jpm7040013

37. Yang, X., Yin, G., Li, Z., Wu, P., Jin, X., & Li, Q. (2019). The preparation and chemical structure analysis of novel POSS-based porous materials. Materials, 12(12), 1954.

https://doi.org/10.3390/ma12121954

38. Schmidt, N. W., Jin, F., Lande, R., Curk, T., Xian, W., Lee, C., Frasca, L., Frenkel, D., Dobnikar, J., Gilliet, M., & Wong, G. C. (2015). Liquid-crystalline ordering of antimicrobial peptide–DNA complexes controls TLR9 activation. Nature Materials, 14(7), 696-700.

https://doi.org/10.1038/nmat4298

39. Yin, H., Tseng, H., Chung, H., Ko, C., Tzou, W., Buhler, D. R., & Hu, C. (2008). Influence of TCDD on Zebrafish CYP1B1 transcription during development. Toxicological Sciences, 103(1), 158-168.

https://doi.org/10.1093/toxsci/kfn035

40. Anselmo, A. C., & Mitragotri, S. (2016). Nanoparticles in the clinic. Bioengineering & Translational Medicine, 1(1), 10-29.

https://doi.org/10.1002/btm2.10003

41. Tsai, W. F., & Lin, H. (2016). The integrity of two sides. Nature Materials, 15(9), 927-928.

https://doi.org/10.1038/nmat4700

42. Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12(11), 991-1003.

https://doi.org/10.1038/nmat3776

43. Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-cas9. Science, 346(6213).

https://doi.org/10.1126/science.1258096

44. Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J., Langer, R., & Farokhzad, O. C. (2009). PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials, 30(8), 1627-1634.

https://doi.org/10.1016/j.biomaterials.2008.12.013

45. Rogers, L., Obasa, A. E., Jacobs, G. B., Sarafianos, S. G., Sönnerborg, A., Neogi, U., & Singh, K. (2018). Structural implications of genotypic variations in HIV-1 Integrase from diverse subtypes. Frontiers in Microbiology, 9.

https://doi.org/10.3389/fmicb.2018.01754

46. Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. C., Tamarkin, L., & Desai, N. (2014). Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences, 1313(1), 35–56.

https://doi.org/10.1111/nyas.12403

47. Parvin, N., Joo, S. W., Jung, J. H., & Mandal, T. K. (2025). Multimodal AI in Biomedicine: Pioneering the Future of Biomaterials, Diagnostics, and Personalized Healthcare. Nanomaterials, 15(12), 895.

https://doi.org/10.3390/nano15120895

48. Bae, H., Ji, H., Konstantinov, K., Sluyter, R., Katsuhiko Ariga, Kim, Y. H., & Kim, J. H. (2025). Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery. Advanced Materials.

https://doi.org/10.1002/adma.202510239

Downloads

Published

2025-08-30

Issue

Vol. 3 No. 8 (2025): Indus Journal of Bioscience Research

Section

Review Article

License

Copyright (c) 2025 Indus Journal of Bioscience Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Muhammad Zubair, Ayomide, B. E., Manzoor, M., Najam, S., Soomro, M., & Binyameen, M. (2025). Pharmaceutical Formulations of Nanotechnology-Based Drug Delivery Systems for Antimicrobial Applications: A Review. Indus Journal of Bioscience Research, 3(8), 473-478. https://doi.org/10.70749/ijbr.v3i8.2176